GT
EXEL icon

Greenleaf Trust’s Exelixis EXEL Stock Holding History

Greenleaf Trust’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+4,560
New +$222K ﹤0.01% 761

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenleaf Trust's EXEL Position: Q2 2026 in Review

Greenleaf Trust opened a new position in Exelixis (EXEL) in Q2 2026: 4,560 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #761 among its holdings.

756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Greenleaf Trust held 4,560 shares of Exelixis worth $248K as of Q2 2026.
  • Exelixis was a new Greenleaf Trust position in Q2 2026.
  • Exelixis made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #761 holding.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.